Budget Amount *help |
¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Outline of Final Research Achievements |
T cell specific deletion using gene deficient mice of sphingolipids demonstrated the complete loss of them in peripheral blood stream. Previous studies demonstrated that GM3 knockout mice showed rheumatism become early onset and aggravated. The total deletion of sphingolipids and GM3, one molecule of sphingolipids showed little difference. On the other hand, a remarkable difference was observed in the colitis model mice. This suggests that amount of ceramide and ceramide-derivatives in cytoplasm participate colitis resistant phenotype of sphingolipids-dificient mice.
|